论文部分内容阅读
结肠癌是近年来临床上常见的一种恶性肿瘤,由于结肠癌早期无典型临床症状、病情隐匿,很难与良性疾病区分。近年来,随着国内外医学界分子生物学诊断技术快速发展,多种肿瘤标志物的作用得到了较为充分的肯定。特别是CD44v6(细胞粘附分子)和Galectin-3(半乳糖凝集素-3)在消化系统恶性肿瘤中的研究正在逐步成为连接临床医学和基础医学的热门课题之一。本文就Galectin-3和CD44v6在结肠
Colon cancer is a common clinical malignant tumor in recent years. Because colon cancer does not have typical clinical symptoms at early stage, its condition is hidden and it is difficult to distinguish it from benign disease. In recent years, with the rapid development of molecular biology diagnostic techniques in the medical field at home and abroad, the role of many tumor markers has been fully affirmed. In particular, studies of CD44v6 (cell adhesion molecule) and Galectin-3 (galectin-3) in digestive system malignancies are gradually becoming one of the hot topics in clinical and basic medicine. In this paper, Galectin-3 and CD44v6 in the colon